New-Onset Diabetes After Transplantation in Renal Recipients: A Pilot Comparative Study of Immediate vs. Extended-Release Tacrolimus Formulation

Tacrolimus is frequently used in immunosuppressive therapy in renal transplant patients and is characterized by high toxicity, a low therapeutic index, and great individual variability. For these reasons, correct dosing is important to ensure patient safety by reducing the incidence of adverse effec...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Ioana Adela Ratiu, Florin Bănică, Corina Moisa, Bianca Pașca, Daniela Gîtea, Iulia Dana Grosu, Gabriel Cristian Bako, Oliviu Voștinaru, Wael Abu Dayyih, Lorena Filip
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	MDPI AG 2025-10-01
Reeks:	Pharmaceuticals
Onderwerpen:	tacrolimus new-onset diabetes after transplantation renal transplantation extended release immediate release drug dissolution
Online toegang:	https://www.mdpi.com/1424-8247/18/10/1532
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!